Table 3.
study | country | location | dates | seroprevalence (%) | this study (%) |
---|---|---|---|---|---|
Havers et al. [6] | USA | Western Washington State | 23 March–1 April 2020 | 1.1 (0.7–1.9) | 1.40 (0.86–2.36) |
New York City metro area | 23 March–1 April 2020 | 6.9 (5.0–8.9) | 1.40 (0.86–2.36) | ||
Louisiana | 1–8 April 2020 | 5.8 (3.9–8.2) | 2.07 (1.41–3.66) | ||
South Florida | 6–10 April 2020 | 1.9 (1.0–3.2) | 2.35 (1.61–4.14) | ||
Philadelphia metro area | 13–25 April 2020 | 3.2 (1.7–5.2) | 3.09 (2.15–5.44) | ||
Missouri | 20–26 April 2020 | 2.7 (1.7–3.9) | 3.34 (2.32–5.88) | ||
Utah | 20 April–3 May 2020 | 2.2 (1.2–3.4) | 3.52 (2.45–6.19) | ||
San Francisco Bay area | 23–27 April 2020 | 1.0 (0.3–2.4) | 3.45 (2.40–6.07) | ||
Connecticut | 26 April–3 May 2020 | 4.9 (3.6–6.5) | 3.68 (2.56–6.47) | ||
Minneapolis–St Paul–St Cloud metro area | 30 April–12 May 2020 | 2.4 (1.0–4.5) | 3.97 (2.76–6.97) | ||
Bendavid et al. [2] | USA | Santa Clara County, California | 3–4 April 2020 | 2.8 (1.3–4.7)a | 1.99 (1.35–3.52) |
Pollán et al. [30] | Spain | nationwide | 27 April–11 May 2020 | 6.2 (5.8–6.6)b | 7.68 (5.35–13.48) |
Hicks et al. [7] | Australia | nationwide | May–June 2020 | 0.28 (0.00–0.71) | 0.06 (0.04–0.10)c |
aWeighted by the authors for the population demographics of Santa Clara County.
bEither point-of-care test or immunoassay positive.
cStatistics are calculated for the period 1 May–30 June 2020.